2-year results of telbivudine (LDT) roadmap study verify the optimal efficacy and safety results in HBeAg positive chronic hepatitis B (CHB) patients
Refereed conference paper presented and published in conference proceedings

香港中文大學研究人員

全文

其它資訊
著者PIRATVISUTH T, KOMOLMET P, TANWANDEE T, SUKEEPAISARNJAOREN W, CHAN Lik Yuen Henry, PESSOA Mg, PESSOA Mg, FASSIO E, ONO-NITA S, BESSONE F, DARUICH J, ZEUZEM S, CHEINQUER H, DONG Y, TRYLESINSKI A
會議名稱annual meeting of European Association for the Study of the Liver
會議論文集題名annual meeting of European Association for the Study of the Liver
詳細描述organized by EASL,
出版年份2012
月份4
頁次1
語言英式英語

上次更新時間 2018-20-01 於 15:17